NCT00699270

Brief Summary

The purpose of this prospective clinical data collection is to document the performance and clinical outcomes of Biomet Humeral Stems

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2007

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2007

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

June 13, 2008

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 17, 2008

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2008

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2008

Completed
Last Updated

June 21, 2017

Status Verified

June 1, 2017

Enrollment Period

1 year

First QC Date

June 13, 2008

Last Update Submit

June 19, 2017

Conditions

Keywords

Total Shoulder ArthroplastyTotal Shoulder ReplacementShoulder Arthritis

Outcome Measures

Primary Outcomes (2)

  • UCLA End Result Score

    3 months, 6 months, 1 year, 3 years, 5 years

  • X-rays

    3 month, 1 year, 3 years, 5 years

Secondary Outcomes (1)

  • Incidence of revisions and removals

    Any time

Study Arms (1)

Biomet Humeral Stems

Biomet Humeral Stems: Comprehensive®, BioModular®, and Bi-Angular® Shoulder Systems

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients that have already made the decision to undergo shoulder replacement surgery and will receive a Biomet humeral stem.

You may qualify if:

  • Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis
  • Rheumatoid Arthritis
  • Correction of functional deformity

You may not qualify if:

  • Absolute contraindications:
  • \- Infection, Sepsis, and Osteomyelitis
  • Relative contraindications:
  • Uncooperative patient or patient with neurologic disorders who is incapable or unwilling to follow directions
  • Osteoporosis
  • Metabolic disorders which may impair bone function
  • Osteomalacia
  • Distant foci of infections which may spread to the implant site
  • Rapid joint destruction, marked bone loss or bone resorption apparent on roentgenogram

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

OsteoarthritisOsteonecrosisArthritis, RheumatoidHumeral Fractures

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesBone DiseasesNecrosisPathologic ProcessesPathological Conditions, Signs and SymptomsConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesArm InjuriesWounds and InjuriesFractures, Bone

Study Officials

  • Kenneth J Beres, MD

    Clinical Research, Biomet Orthopedics, LLC

    STUDY DIRECTOR
0

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 13, 2008

First Posted

June 17, 2008

Study Start

August 1, 2007

Primary Completion

August 1, 2008

Study Completion

December 1, 2008

Last Updated

June 21, 2017

Record last verified: 2017-06